GLUCOSE ISOMERASE FROM STREPTOMYCES RUBIGINOSUS
Glucose isomerase from Streptomyces rubiginosus is a microbial enzyme preparation used in industrial food processing to convert glucose to fructose, particularly in the production of high fructose syrups.
What It Is
Glucose isomerase from Streptomyces rubiginosus is a microbial enzyme preparation that functions as a biocatalyst in food processing and ingredient manufacture. This enzyme is classified as an isomerase, specifically a D-xylose ketol-isomerase (EC 5.3.1.5), and it catalyzes the reversible conversion of glucose to fructose. Its primary application in food processing is in the production of high fructose corn syrup and related fructose-enriched syrups that serve as sweetening ingredients in a broad array of processed foods. The substance is referenced by the Chemical Abstracts Service (CAS) number 977090-06-4, which uniquely identifies it in chemical and regulatory databases. Enzymes like glucose isomerase are classified technically as catalysts rather than nutrients or conventional food additives because they facilitate chemical transformations during processing rather than contribute directly to the food mass that consumers ingest. In regulatory contexts, it is recognized as an enzyme preparation, not a flavoring or preservative, and is typically used in immobilized form on inert carriers to facilitate repeated use and removal from the process stream. Multiple synonyms exist for the enzyme, often reflecting its source and catalytic activity, including “xylose isomerase" and simply “glucose isomerase" when referring to the activity of Streptomyces-derived preparations. The designation of this enzyme in regulatory listings typically groups it among microbial enzyme preparations that have been assessed for safety in food production. Because it acts on monosaccharides under controlled conditions during manufacturing, glucose isomerase does not contribute a conventional taste profile to food products. Instead, its presence is transient and functional, existing within manufacturing workflows to influence the sugar profile of ingredients like syrups. Its use is grounded in biochemical specificity and catalytic efficiency rather than sensory impact, and regulatory language reflects its technical function rather than nutritional contribution.
How It Is Made
The production of glucose isomerase from Streptomyces rubiginosus involves standard industrial enzyme biotechnology processes built around microbial fermentation. Production typically starts with a selected nonpathogenic strain of Streptomyces rubiginosus, which is cultivated under controlled fermentation conditions to produce the target enzyme at high yield. Fermentation media are optimized for nutrient balance, pH, and temperature to maximize microbial growth and enzyme expression. Once the fermentation reaches a predefined stage, cells are harvested and disrupted to release the intracellular enzyme. Downstream processing steps often include clarification to remove cell debris, concentration of soluble protein fractions, and purification tailored to the intended form of the enzyme product. In many commercial applications for food processing, the enzyme is subsequently immobilized on an inert support matrix. Immobilization involves fixing the enzyme onto a solid phase, such as ion-exchange resins or other food-grade carriers, which facilitates repeated use of the enzyme in industrial reactors and simplifies separation from processed material. Immobilization also enhances enzyme stability and operational lifetime during continuous processing. Fixed-bed reactors or packed columns are common configurations where immobilized glucose isomerase is deployed to catalyze the conversion of glucose to fructose in starch hydrolysates. The manufacturing process must adhere to regulatory standards for enzyme preparations intended for food use. Specifications commonly reference compendial standards such as the Food Chemicals Codex for purity and identity. Quality control measures evaluate enzyme activity units, absence of viable production organisms, and compliance with defined physical and chemical criteria. Because the enzyme is derived from microbial fermentation, processes incorporate steps to ensure that residual production strain cells and genetic material are absent from the final immobilized preparation, reflecting safety assessment requirements. These controls help ensure that the enzyme preparation fulfills regulatory expectations for use in food processing without contributing microbial contaminants or unintended substances to the food supply.
Why It Is Used In Food
Glucose isomerase from Streptomyces rubiginosus is used in food manufacturing because it catalyzes the isomerization of glucose to fructose, a conversion that is central to producing high fructose syrups. High fructose syrups are liquid sweeteners with specific fructose contents that influence sweetness intensity and physical properties in foods. The enzyme’s catalytic specificity enables manufacturers to transform inexpensive glucose-rich starch hydrolysates into sweeter fructose-enriched syrups without resorting to chemical treatments. This enzymatic route offers high selectivity, operates under relatively mild conditions, and supports predictable product profiles in terms of sugar composition. The use of glucose isomerase supports economic and technical goals in sweetener production. Fructose exhibits a higher relative sweetness compared to glucose, which can allow manufacturers to achieve target sweetness with lower total sweetener loads. As a result, fructose-enriched syrups produced with glucose isomerase find broad use in foods where a high degree of sweetness is required, such as beverages, confectionery, baked goods, dairy desserts, and sauces. The enzyme’s action affects not only sweetness but also functional properties like freezing point depression and viscosity, which can be important in formulating diverse food matrices. In addition to sweetness modulation, enzymatic production of fructose-containing syrups aligns with consumer and industry interest in biotechnological processing. Using a biological catalyst rather than harsh chemical treatments supports processing under conditions of current good manufacturing practice for enzyme use. The immobilized form of glucose isomerase is especially valuable because it allows for continuous processing with minimal enzyme loss and ease of separation from product streams. The resulting high fructose syrups are tailored intermediates for food formulation, enabling consistent sugar profiles across production lots and supporting the broad palette of sweetened foods where such syrups are functional ingredients.
Adi Example Calculation
An illustrative example of how an acceptable daily intake calculation might work for a conventional food additive can help explain the concept, although it is important to emphasize that for enzyme preparations like glucose isomerase immobilized in industrial processes, such calculations are not typically applied due to negligible dietary exposure. Hypothetically, if a substance had an ADI of a certain number of milligrams per kilogram of body weight per day, a person weighing 70 kilograms would multiply that ADI value by 70 to determine the maximum amount considered safe per day for that individual. For example, for a substance with an ADI of X mg per kilogram body weight, the calculation for a 70 kilogram adult would be X times 70, yielding a value in milligrams per day that reflects the conservative safety threshold across a lifetime of exposure. It is important to note that the result of such a calculation is a regulatory construct intended to guide safety assessment and risk management. It does not represent a recommended intake level, and exceeding the calculated number on a given day would not necessarily imply harm if exposure is occasional. Regulatory bodies use these calculations to support evaluations of ingredients that are deliberately added to foods and are present at measurable levels in final products. In contrast, enzyme preparations used solely as processing aids are assessed for their role in manufacturing and their removal or inactivation prior to consumption, rather than being assigned specific ADI values for dietary intake. This example illustrates the broader regulatory framework without implying that the enzyme itself has a defined ADI for consumers.
Safety And Health Research
Safety and health research related to glucose isomerase from Streptomyces rubiginosus centers on toxicological evaluations, allergenicity assessment, and process-related considerations rather than direct physiological effects of the enzyme in consumers. Because the enzyme is used in industrial processing and is not present in significant amounts in final consumer products, exposure assessment focuses on residual implications of processing and potential traces rather than on direct dietary intake of the active enzyme. Toxicological studies reported in regulatory evaluations have included genotoxicity tests and repeated-dose oral toxicity studies conducted in laboratory animals. These assessments generally support the conclusion that, under defined processing conditions with immobilized enzyme preparations, there are no safety concerns that would preclude regulatory acceptance for food ingredient manufacture. Allergenicity assessment is a component of safety research for food enzymes produced by microbial fermentation. Protein sequence comparisons to known allergens and evaluation of potential sensitization risks contribute to understanding whether enzyme residues could pose allergic risks. In evaluations conducted for regulatory submissions in certain jurisdictions, no significant similarity to known allergens was identified, and the likelihood of allergic reactions by dietary exposure was considered low. Nonetheless, because enzymes are proteins, the possibility of sensitization cannot be wholly excluded, and this consideration informs labeling and manufacturing controls rather than direct health claims. Process-related safety research emphasizes the importance of removing production strain cells, DNA, and total organic solids from enzyme preparations destined for use in food production. Regulatory assessments take into account the immobilization of the enzyme and downstream purification steps that reduce potential exposure to unintended components. This focus aligns with broader regulatory safety paradigms that differentiate between processing aids and food additives, where processing aids like immobilized enzymes are not intended to remain active or present in finished foods. As a result, safety research and regulatory evaluation prioritize manufacturing controls, purity specifications, and evidence from toxicological data in supporting enzyme use within authorized frameworks.
Regulatory Status Worldwide
Regulatory frameworks in multiple jurisdictions have evaluated glucose isomerase from Streptomyces rubiginosus for safety and appropriate use in food processing. In the United States, the enzyme preparation is specifically addressed under Title 21 of the Code of Federal Regulations, section 184.1372, which affirms insoluble glucose isomerase enzyme preparations as direct food substances affirmed as generally recognized as safe when used in accordance with current good manufacturing practice. This regulatory listing reflects a safety evaluation that considers the source organism, production methods, and technical function of the enzyme in processing high fructose corn syrup and related ingredients. Under this provision, the enzyme is permitted without a specified use limit other than adherence to stated good manufacturing practices and is identified as derived from nonpathogenic and nontoxicogenic microorganisms grown in pure culture fermentation processes. In the European Union, the European Food Safety Authority conducted a comprehensive safety evaluation of a food enzyme preparation of xylose isomerase from a genetically modified strain of Streptomyces rubiginosus. The assessment concluded that, under the intended conditions of use in the production of high fructose syrups with immobilized enzyme systems, there were no safety concerns arising from dietary exposure. The panel’s opinion considered toxicological data, residual total organic solids, and the absence of production strain cells or DNA in the final enzyme preparation, informing the regulatory context for enzyme approvals in the EU. At the international level, the Joint FAO/WHO Expert Committee on Food Additives has evaluated glucose isomerase preparations. Historical evaluations distinguished between immobilized and non-immobilized forms, with no acceptable daily intake (ADI) allocated for non-immobilized enzyme due to lack of specific use data and an acceptance of immobilized forms under defined processing conditions. Specifications and functional class designations have been developed for enzyme preparations in international food additive compendia. Together, these regulatory assessments reflect broad recognition of glucose isomerase’s technical role in ingredient processing, with safety considerations focused on production controls, absence of viable production organisms, and proper use within current good manufacturing practice frameworks.
Taste And Functional Properties
Glucose isomerase from Streptomyces rubiginosus does not itself contribute a taste profile to foods because it is not typically present in the final consumer products. Instead, its functional contribution arises from its catalytic activity during processing, where it converts glucose molecules into fructose. Fructose is sweeter than glucose on a weight basis, which means that products formulated with fructose-enriched syrups often exhibit heightened sweetness relative to those containing only glucose-based sweeteners. This enzymatic transformation influences functional properties such as sweetness perception, hygroscopicity, and freezing point depression in finished foods. From a physical chemistry perspective, fructose interacts differently with water and other ingredients compared to glucose, which can affect texture and mouthfeel in products like frozen desserts and beverages. The relative sweetness of fructose also contributes to flavor balance in complex formulations, often allowing formulators to reduce total sugar content while maintaining desired sweetness. However, the sensory impact of the resulting syrup is a function of its composition rather than the enzyme itself, which is removed or inactive in finished goods. Functionally, glucose isomerase exhibits activity under specific pH and temperature conditions optimized for industrial reactors. Enzyme stability is influenced by immobilization strategies, which help maintain activity over prolonged use and under continuous processing conditions. While free enzymes may lose activity more rapidly, immobilized preparations can withstand operational demands, enhancing process efficiency. The enzyme does not remain active in the final food product because processing steps and purification remove or inactivate it, and it is not intended as a digestive enzyme for consumer use. In this way, taste and functional outcomes in finished foods derive from the enzymatically modified ingredients produced during processing rather than residual enzyme activity in the product consumed by individuals.
Acceptable Daily Intake Explained
An acceptable daily intake (ADI) is a regulatory concept used by international food safety authorities to express the amount of a substance that can be ingested daily over a lifetime without appreciable health risk. In the context of enzyme preparations used in food processing, the notion of an ADI is often not directly applied in the same way as it is for conventional food additives because these enzymes are processing aids that are not intended to be present in consumer products at significant levels. For glucose isomerase from Streptomyces rubiginosus, historical evaluations by international expert committees distinguished between immobilized enzyme preparations and non-immobilized enzyme forms in terms of data available for setting an ADI. The immobilized enzyme was considered acceptable for use in food processing systems under defined conditions, while non-immobilized forms did not have an ADI allocated due to insufficient use data. This reflects the regulatory perspective that enzyme preparations acting as catalysts during manufacturing are evaluated chiefly on technical function and process safety rather than consumer intake. When toxicological data are available for enzymes or other food substances, expert committees apply large safety factors to account for uncertainties in extrapolating results from animal studies to humans. These safety factors may incorporate considerations of variability within human populations as well as differences between test animals and humans. Because immobilized enzyme preparations are used in continuous industrial systems with minimal carryover into finished foods, exposure assessment often concludes that dietary exposure to the active enzyme is negligible. In such cases, regulators may determine that an explicit ADI value is unnecessary, relying instead on process controls and good manufacturing practices to ensure safety. This regulatory approach underscores that ADI is not a recommended intake level but rather a threshold below which risk is considered negligible based on available evidence and expert judgment.
Comparison With Similar Additives
Comparing glucose isomerase from Streptomyces rubiginosus with other enzyme preparations used in food processing highlights both shared features and distinct functional roles. Like lactase enzyme preparations, which catalyze the hydrolysis of lactose into glucose and galactose in dairy products, glucose isomerase serves a catalytic role in transforming one sugar into another to achieve desired ingredient characteristics. Both enzymes are typically used in immobilized or purified forms and are evaluated for safety on the basis of manufacturing controls, absence of harmful residues, and functional efficacy rather than direct nutritive contributions to final foods. By contrast, enzymes such as alpha-amylase are used to hydrolyze complex carbohydrates like starch into simpler sugars during processes such as brewing or baking. While alpha-amylase and glucose isomerase both influence carbohydrate profiles, their roles differ: alpha-amylase breaks down large polysaccharides into smaller units, whereas glucose isomerase specifically rearranges a monosaccharide into a structural isomer. This difference in catalytic activity reflects distinct applications in food processing, with alpha-amylase often influencing texture and fermentable sugar availability, and glucose isomerase influencing relative sweetness and fructose content. Another comparison can be made with protease preparations used in protein hydrolysis for flavor development or texture modification in foods like cheese and meat products. Proteases act on peptide bonds, whereas glucose isomerase acts on carbohydrate substrates. Despite the differences in substrate and effect, all these enzymes share common regulatory considerations: they must be produced under controlled fermentation or extraction processes, meet purity specifications, and be used in accordance with good manufacturing practices. These comparisons underscore that enzyme preparations serve as technical tools in food processing, with specific catalytic functions tailored to particular ingredients or formulation goals, and are assessed for safety and efficacy within regulatory frameworks appropriate for processing aids rather than conventional food additives.
Common Food Applications Narrative
In the landscape of modern food production, glucose isomerase from Streptomyces rubiginosus plays an essential role in generating sugar ingredients that are building blocks for many consumer products. The enzyme’s ability to convert glucose into fructose underpins the manufacture of high fructose syrups, which are versatile sweetening agents used across a broad spectrum of foods. High fructose corn syrup and related fructose-enriched sugar syrups are foundational in beverages, baked goods, confectionery, breakfast cereals, sauces, and snacks where consistent sweetness and functional behavior are important. These syrups serve as source materials that food formulators incorporate to achieve desired sensory profiles and processing characteristics. Beverages represent one of the largest categories where fructose-enriched syrups derived through glucose isomerase application are used. Carbonated drinks, ready-to-drink teas, fruit-flavored beverages, and sports drinks often rely on these syrups for sweetness and mouthfeel. In baked goods, the fructose content can influence browning reactions and moisture retention, enhancing texture and shelf stability. Confectionery products, such as candies and fillings, benefit from the elevated relative sweetness and favorable crystallization behavior of syrups with higher fructose content. Similarly, dairy-based desserts and frozen treats use these syrups to modulate freezing point and sweetness while supporting smooth texture. Beyond sweetness, food manufacturers leverage the functional attributes of high fructose syrups in sauces, dressings, and condiments where viscosity and stability are key. For example, sweet-and-sour sauces and barbecue glazes use fructose-enriched syrups to balance flavor and contribute to the desired consistency. Snack bars and energy foods incorporate these syrups as binders that help achieve uniform distribution of ingredients. Overall, the common thread across these applications is that glucose isomerase facilitates the creation of ingredient intermediates that drive formulation flexibility, sweetness profiles, and technical performance in a wide array of processed foods where consumers expect consistent taste and quality.
Safety & Regulations
FDA
- Approved: True
- Regulation: 21 CFR 184.1372
EFSA
- Notes: EFSA safety evaluation concluded no concerns under intended use conditions
- Approved: True
JECFA
- Notes: No ADI allocated for non immobilized form and acceptable status for immobilized forms without numeric ADI
Comments
Please login to leave a comment.
No comments yet. Be the first to share!